Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZFP61 mRNA | CTD | PMID:36041667 | 6-propyl-2-thiouracil | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZFP61 mRNA | CTD | PMID:30047161 | acrylamide | increases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of ZFP61 mRNA | CTD | PMID:28959563 | amitrole | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZFP61 mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ZNF233 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ZFP61 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | ZNF233 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF233 exon and Benzo(a)pyrene results in decreased methylation of ZNF233 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | ZNF233 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF233 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ZFP61 3' UTR and Benzo(a)pyrene results in increased methylation of ZFP61 exon | CTD | PMID:27901495 | bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of ZFP61 mRNA | CTD | PMID:15674844 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of ZFP61 mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ZFP61 mRNA] | CTD | PMID:19850644 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZFP61 mRNA | CTD | PMID:26063408 | bisphenol A | multiple interactions | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZFP61 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ZNF233 mRNA | CTD | PMID:31715268 | bisphenol A | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZFP61 mRNA | CTD | PMID:25181051 more ... | bisphenol F | multiple interactions | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZFP61 mRNA | CTD | PMID:36041667 | chloroprene | increases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of ZFP61 mRNA | CTD | PMID:23125180 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP61 mRNA | CTD | PMID:20938992 | copper atom | increases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP61 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP61 mRNA | CTD | PMID:30556269 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP61 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP61 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | ZNF233 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF233 mRNA | CTD | PMID:27188386 | entinostat | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | entinostat results in increased expression of ZNF233 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP61 mRNA | CTD | PMID:20938992 | gentamycin | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP61 mRNA | CTD | PMID:33387578 | ketamine | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of ZFP61 mRNA | CTD | PMID:20080153 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP61 mRNA | CTD | PMID:20938992 | lead(0) | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Lead results in increased expression of ZNF233 mRNA | CTD | PMID:19921347 | methimazole | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZFP61 mRNA | CTD | PMID:30047161 | methotrexate | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of ZNF233 mRNA | CTD | PMID:24449571 | nitrofen | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of ZFP61 mRNA | CTD | PMID:33484710 | paracetamol | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ZFP61 mRNA | CTD | PMID:33387578 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ZFP61 mRNA | CTD | PMID:30047161 | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of ZNF233 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | ZNF233 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF233 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of ZFP61 mRNA | CTD | PMID:19073995 and PMID:33720480 | sulfadimethoxine | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of ZFP61 mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ZNF233 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ZNF233 mRNA | CTD | PMID:31758290 | titanium dioxide | decreases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | titanium dioxide results in decreased expression of ZNF233 mRNA | CTD | PMID:34973136 | titanium dioxide | increases methylation | ISO | ZNF233 (Homo sapiens) | 6480464 | titanium dioxide results in increased methylation of ZNF233 gene | CTD | PMID:34973136 | trichloroethene | decreases expression | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ZFP61 mRNA | CTD | PMID:33387578 | trichloroethene | increases methylation | ISO | Znf235-ps1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of ZFP61 gene | CTD | PMID:27618143 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of ZFP61 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ZNF233 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZNF233 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | ZNF233 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF233 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ZNF233 mRNA | CTD | PMID:23179753 and PMID:26272509 | vorinostat | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | vorinostat results in increased expression of ZNF233 mRNA | CTD | PMID:27188386 | zinc sulfate | increases expression | ISO | ZNF233 (Homo sapiens) | 6480464 | Zinc Sulfate results in increased expression of ZNF233 mRNA | CTD | PMID:16330358 | |